/Investor DB

DeepWork Capital — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Genascencegenascence.comSeries A · Jan 2022 · $11M

Genascence develops gene therapy treatments for musculoskeletal diseases, with a focus on osteoarthritis.

BiotechHealthtech

TSO Lifetsolife.cominSeries A · Oct 2022 · $9M

Wesley Chapel, US

David Sawyer(Executive Officer, Director)inRalph Stoddard(Director)Stella Parris(Executive Officer)Margaret Sawyer(Director)

BoardKATIE SCHMITZ(Director)JUSTIN KELLY(Director)

Co-investorsBeresford VenturesFlorida FundersJohnson Venture PartnersThird Act Ventures

Urban SDKurbansdk.comin𝕏Seed · Jan 2022 · $2M

Urban SDK provides geospatial AI technology for public sector organizations, particularly city governments and transportation agencies, to support data-driven decision-making for urban planning and traffic analytics.

AI & Machine LearningData & InfrastructureGovTechMobility & TransportationAtlantic Beach, US

Justin J. Dennis(Executive Officer, Director)Drew Messer(Founder)inMeredith Pelton(Director)

BoardMitchel Laskey(Director)inJonathan Kilman(Director)

Co-investorsCreativeCoFlorida Opportunity FundGOVO Venture PartnersRiverwood CapitalTechstarsVentureSouth+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.